EMA Authorised: Irbesartan Zentiva (previously Irbesartan Winthrop) (irbesartan) — Zentiva k.s.

View source ↗

Summary

The EMA has authorised Irbesartan Zentiva, a Reformulated/renamed irbesartan product for hypertension, under Zentiva k.s. as the marketing authorization holder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Irbesartan Zentiva (irbesartan)

Snippet

Status: Authorised. Therapeutic area: Hypertension. MAH: Zentiva k.s.. Decision date: 23/07/2026